Clinical Trials Directory

Trials / Completed

CompletedNCT01453738

Allogeneic Mesenchymal Stem Cells in Osteoarthritis

A Randomized, Double Blind, Multicentric, Placebo Controlled, Phase -II Study Assessing the Safety and Efficacy of Intraarticular Ex-vivo Cultured Adult Allogeneic Mesenchymal Stem Cells in Patients With Osteoarthritis of Knee

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Stempeutics Research Pvt Ltd · Industry
Sex
All
Age
40 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This trial is planed to study if allogeneic mesenchymal stem cells would be safe and beneficial in osteoarthritis of knee joint. This is a double blind study. Different doses of stem cells will be used in this study.

Conditions

Interventions

TypeNameDescription
BIOLOGICALEx- vivo cultured adult allogeneic MSCsSingle intraarticular dose of allogeneic MSCs suspended in 2ml Plasmalyte followed by 2ml of Hyaluronan
BIOLOGICALPlasmalyte-ASingle intraarticular dose of 2ml Plasmalyte followed by 2ml Hyaluronan

Timeline

Start date
2011-11-01
Primary completion
2014-11-01
Completion
2014-11-01
First posted
2011-10-18
Last updated
2016-05-12

Locations

5 sites across 1 country: India

Source: ClinicalTrials.gov record NCT01453738. Inclusion in this directory is not an endorsement.

Allogeneic Mesenchymal Stem Cells in Osteoarthritis (NCT01453738) · Clinical Trials Directory